A new international study coordinated by the European Alzheimer's and Dementia Biobank (EADB) consortium sheds light on how genetic risk factors for Alzheimer's disease (AD) vary—and remain ...

DOI: 10.1038/s44400-025-00013-3 People with better cognitive health are at lower risk of later Alzheimer's disease, but genetics can interfere with this, according to a new study.

Desert June is Alzheimer’s and Brain Awareness Month. More than 7 million Americans ages 65 and older are living with Alzheimer’s disease right now, according to the Alzheimer’s Association.

Researchers say a new blood test for Alzheimer's disease has been shown to be highly accurate in detecting people with early symptoms. Scientists looked for two proteins - amyloid beta 42/40 and p ...

Researchers at the Mayo Clinic in the U.S. have been working on a new blood test that can accurately detect early signs of Alzheimer’s disease, and the results are seriously impressive.

Two drugs to treat Alzheimer’s disease have been rejected for use on the NHS because their benefits are “too small” to justify their cost, the health spending watchdog has said.

Using a mouse model of Alzheimer’s disease — that were later verified in human Alzheimer’s disease brain tissue samples — researchers found that exercise changed activity in the ...

Alzheimer's disease affects millions of people around the world and occurs when abnormal proteins build up in the brain, leading to the death of brain cells and declines in cognitive function and ...

Alzheimer’s disease, a progressive neurodegenerative disease that causes decreased memory and cognitive function, affects more than 7 million people in the U.S. alone.

A new era in Alzheimer disease detection may be on the horizon with the development of a novel blood test. 1,2 This diagnostic tool, known as Penta-Plex Alzheimer’s Disease Capture Sandwich ...

The link between menopause and Alzheimer's disease has a growing scientific interest from researchers. FOX 17's Janice Allen speaks with Dr. Celia Egan to learn more.

Two breakthrough Alzheimer's drugs have been deemed far too expensive, for too little benefit, to be offered on the NHS. The medicines are the first to slow the disease, which may give people ...